Recent highlights from the on challenges for adequate stroke prevention in patients with atrial fibrillation.
作者信息
Fender Anke C, Dobrev Dobromir
机构信息
Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.
Department of Integrative Physiology, Baylor College of Medicine, Houston, USA.
出版信息
Int J Cardiol Heart Vasc. 2023 Aug 21;48:101259. doi: 10.1016/j.ijcha.2023.101259. eCollection 2023 Oct.
Abstract
摘要
相似文献
1
Recent highlights from the on challenges for adequate stroke prevention in patients with atrial fibrillation.
Int J Cardiol Heart Vasc. 2023 Aug 21;48:101259. doi: 10.1016/j.ijcha.2023.101259. eCollection 2023 Oct.
2
Recent highlights from the : Comprehensive management of atrial fibrillation.
Int J Cardiol Heart Vasc. 2024 Jul 29;53:101478. doi: 10.1016/j.ijcha.2024.101478. eCollection 2024 Aug.
3
Highlights from the International Journal of Cardiology Heart & Vasculature: Heart failure, atrial fibrillation, coronary artery disease and myocardial infarction.
Int J Cardiol Heart Vasc. 2019 Nov 20;25:100443. doi: 10.1016/j.ijcha.2019.100443. eCollection 2019 Dec.
4
Recent highlights on myocarditis and cardiomyopathies from the and .
Int J Cardiol Heart Vasc. 2023 Nov 27;49:101315. doi: 10.1016/j.ijcha.2023.101315. eCollection 2023 Dec.
5
European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care.
Eur J Prev Cardiol. 2016 Mar;23(5):460-73. doi: 10.1177/2047487315571890. Epub 2015 Feb 20.
6
[Italian Society of Interventional Cardiology (SICI-GISE) Position paper: Transcatheter left atrial appendage occlusion in patients with non-valvular atrial fibrillation].
G Ital Cardiol (Rome). 2022 Feb;23(2):136-154. doi: 10.1714/3735.37217.
7
[Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation].
Herzschrittmacherther Elektrophysiol. 2016 Sep;27(3):295-306. doi: 10.1007/s00399-016-0447-1.
8
Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology.
Eur Heart J Acute Cardiovasc Care. 2020 Jun;9(4):348-357. doi: 10.1177/2048872619894255. Epub 2020 Jan 24.
9
Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
Consult Pharm. 2014 Mar;29(3):169-78. doi: 10.4140/TCP.n.2014.169.
10
Electrical cardioversion for atrial fibrillation and flutter.
Cochrane Database Syst Rev. 2002(1):CD002903. doi: 10.1002/14651858.CD002903.
引用本文的文献
1
Recent highlights from the : cardio-oncology.
Int J Cardiol Heart Vasc. 2025 Aug 27;60:101780. doi: 10.1016/j.ijcha.2025.101780. eCollection 2025 Oct.
2
Inflammatory gut-heart interactions: Is there a link between inflammatory bowel disease and atrial fibrillation?
Int J Cardiol Heart Vasc. 2024 Oct 16;55:101537. doi: 10.1016/j.ijcha.2024.101537. eCollection 2024 Dec.
本文引用的文献
1
Recent highlights on thrombosis and hemostasis from the International Journal of Cardiology: Heart & Vasculature.
Int J Cardiol Heart Vasc. 2022 Dec;43:101145. doi: 10.1016/j.ijcha.2022.101145. Epub 2022 Nov 5.
2
Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral Anticoagulant.
Int J Cardiol Heart Vasc. 2022 Oct 10;43:101130. doi: 10.1016/j.ijcha.2022.101130. eCollection 2022 Dec.
3
Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19.
Int J Cardiol Heart Vasc. 2022 Sep 27;43:101127. doi: 10.1016/j.ijcha.2022.101127. eCollection 2022 Dec.
4
Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit.
Int J Cardiol Heart Vasc. 2022 Sep 12;42:101117. doi: 10.1016/j.ijcha.2022.101117. eCollection 2022 Oct.
5
Barriers to stroke prevention in Atrial Fibrillation: Insights from the global anticoagulation Roundtable.
Int J Cardiol Heart Vasc. 2022 Aug 1;42:101096. doi: 10.1016/j.ijcha.2022.101096. eCollection 2022 Oct.
6
A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection.
Int J Cardiol Heart Vasc. 2022 Aug;41:101068. doi: 10.1016/j.ijcha.2022.101068. Epub 2022 Jun 3.
7
The temporal context of oral anticoagulation outcome in atrial fibrillation.
Int J Cardiol Heart Vasc. 2022 May 13;40:101051. doi: 10.1016/j.ijcha.2022.101051. eCollection 2022 Jun.
8
On-treatment follow-up in real-world studies of direct oral anticoagulants in atrial fibrillation: Association with treatment effects.
Int J Cardiol Heart Vasc. 2022 Apr 4;40:101024. doi: 10.1016/j.ijcha.2022.101024. eCollection 2022 Jun.
9
Age-dependent risk for thromboembolism in atrial fibrillation: The Fushimi AF registry.
Int J Cardiol Heart Vasc. 2022 May 19;41:101055. doi: 10.1016/j.ijcha.2022.101055. eCollection 2022 Aug.
10
Clinical features and outcomes of patients in different age groups with non-valvular atrial fibrillation receiving oral anticoagulants.
Int J Cardiol Heart Vasc. 2022 Mar 28;40:101009. doi: 10.1016/j.ijcha.2022.101009. eCollection 2022 Jun.
Zotero 插件